Connor Clark & Lunn Investment Management Ltd. Raises Holdings in Nu Skin Enterprises, Inc. $NUS

Connor Clark & Lunn Investment Management Ltd. raised its stake in Nu Skin Enterprises, Inc. (NYSE:NUSFree Report) by 52.5% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 396,639 shares of the company’s stock after purchasing an additional 136,511 shares during the quarter. Connor Clark & Lunn Investment Management Ltd. owned 0.80% of Nu Skin Enterprises worth $3,169,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in NUS. Vanguard Group Inc. increased its position in shares of Nu Skin Enterprises by 4.9% in the first quarter. Vanguard Group Inc. now owns 4,133,109 shares of the company’s stock valued at $30,006,000 after acquiring an additional 193,038 shares during the period. Prescott Group Capital Management L.L.C. grew its stake in shares of Nu Skin Enterprises by 142.7% in the 1st quarter. Prescott Group Capital Management L.L.C. now owns 1,394,608 shares of the company’s stock worth $10,125,000 after buying an additional 819,972 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Nu Skin Enterprises by 7.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,319,885 shares of the company’s stock valued at $9,582,000 after buying an additional 88,088 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Nu Skin Enterprises by 47.1% in the first quarter. Charles Schwab Investment Management Inc. now owns 1,052,384 shares of the company’s stock worth $7,640,000 after acquiring an additional 336,807 shares in the last quarter. Finally, American Century Companies Inc. increased its holdings in shares of Nu Skin Enterprises by 15.0% during the first quarter. American Century Companies Inc. now owns 948,710 shares of the company’s stock valued at $6,888,000 after acquiring an additional 123,971 shares in the last quarter. Institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Stock Performance

Nu Skin Enterprises stock opened at $9.66 on Friday. Nu Skin Enterprises, Inc. has a twelve month low of $5.32 and a twelve month high of $14.62. The company has a quick ratio of 1.38, a current ratio of 2.01 and a debt-to-equity ratio of 0.27. The company’s 50-day moving average price is $11.13 and its 200-day moving average price is $9.59. The company has a market cap of $477.90 million, a PE ratio of 4.80 and a beta of 0.97.

Nu Skin Enterprises (NYSE:NUSGet Free Report) last posted its quarterly earnings data on Thursday, November 6th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.04. The business had revenue of $364.21 million during the quarter, compared to analyst estimates of $374.20 million. Nu Skin Enterprises had a return on equity of 8.23% and a net margin of 6.20%. Nu Skin Enterprises has set its FY 2025 guidance at 1.250-1.350 EPS. Q4 2025 guidance at 0.250-0.350 EPS. On average, equities research analysts forecast that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 10th. Investors of record on Friday, November 28th will be given a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend is Friday, November 28th. Nu Skin Enterprises’s dividend payout ratio is 11.01%.

Analyst Upgrades and Downgrades

NUS has been the topic of a number of recent analyst reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Nu Skin Enterprises in a report on Wednesday, October 8th. Zacks Research upgraded Nu Skin Enterprises to a “hold” rating in a research note on Tuesday, August 12th. Finally, Wall Street Zen downgraded shares of Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Three analysts have rated the stock with a Hold rating, According to MarketBeat.com, Nu Skin Enterprises presently has an average rating of “Hold” and a consensus target price of $7.00.

Read Our Latest Analysis on NUS

Insiders Place Their Bets

In related news, Director Laura Nathanson sold 6,489 shares of the business’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $12.22, for a total transaction of $79,295.58. Following the completion of the transaction, the director owned 33,149 shares in the company, valued at $405,080.78. The trade was a 16.37% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Chayce David Clark sold 20,000 shares of the company’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $11.97, for a total value of $239,400.00. Following the completion of the transaction, the executive vice president directly owned 233,140 shares in the company, valued at $2,790,685.80. This trade represents a 7.90% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 58,926 shares of company stock valued at $711,364 over the last 90 days. Insiders own 2.00% of the company’s stock.

Nu Skin Enterprises Company Profile

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Featured Articles

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUSFree Report).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.